Invesaro

Stocks WMB Financial statements

Financial statements

WILLIAMS COMPANIES, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data WILLIAMS COMPANIES, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue7,4998,0318,6868,2017,71912,78417,77311,99612,63214,899
Selling, general and administrative722594569558466558636665708
General and administrative665708721
Operating income6899277681,9212,2022,6313,0184,3113,3394,196
Interest expense1,1791,0831,1121,1861,1721,1791,1471,2361,3641,442
Interest income715796740
Other non-operating income85-259233-436189910869
Pre-tax income-3755353311,0642772,0732,5424,4052,9863,625
Income tax-25-1,974138335795114251,005640857
Income from continuing operations-4242,174-1568622081,5142,0463,273
Net income to minority interests74335348-136-134568124121150
Net income-4242,174-1558502111,5172,0493,1792,2252,618
EBITDA2,4522,6632,4933,6353,9234,4735,0276,3825,5586,543
EPS, basic-0.572.63-0.160.700.171.251.682.611.822.14
EPS, diluted-0.572.62-0.160.700.171.241.672.601.822.14
Shares, basic (weighted)7518269741,2121,2141,2151,2181,2181,2191,221
Shares, diluted (weighted)7518299741,2141,2151,2181,2231,2231,2231,225
Dividend per share1.681.201.361.521.601.641.701.791.902.00

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents1708991682891421,6801522,1506063
Receivables9389769929969991,9782,7231,6551,8632,084
Inventory138113130125136379320274279314
Other current assets216191174170149211279195191256
Total current assets1,4622,1791,4641,5801,4294,5493,7974,5132,6613,244
Property, plant and equipment28,42828,21127,50429,20028,92929,25830,88934,31138,69241,996
Lease right-of-use assets207182159162159154170
Goodwill47018800463466466
Other non-current assets5816197461,0661,2041,2761,3191,5731,8302,011
Total assets46,83546,35245,30246,04044,16547,61248,43352,62754,53258,573
Accounts payable6239786625524821,7462,3271,3791,6132,224
Accrued liabilities1,4481,1671,1021,2769441,0351,2701,284285
Deferred revenue338361244158129134141159170
Short-term debt785501472,1408932,0256272,3371,7201,345
Total current liabilities2,9492,6461,8113,9682,3194,9724,8905,8305,3126,106
Long-term debt22,62420,43422,36720,14821,45121,65021,92723,37624,73627,316
Lease liabilities188161141148148142151
Total liabilities32,78930,17729,30529,67629,58233,51134,38837,73639,69243,578
Total debt23,40920,93522,41422,28822,34423,67522,55425,71326,45628,661
Paid-in capital14,88718,50824,69324,32324,37124,44924,54224,57824,64324,801
Retained earnings-9,649-8,434-10,002-11,002-12,748-13,237-13,271-12,287-12,396-12,237
Treasury stock-1,041-1,041-1,041-1,041-1,041-1,041-1,050-1,180-1,180-1,180
Other comprehensive income-339-238-270-199-96-33-24076127
Shareholders' equity4,6439,65614,66013,36311,76911,42311,48512,40212,43612,807
Minority interests9,4036,5191,3373,0012,8142,6782,5602,4892,4042,188
Total equity14,04616,17515,99716,36414,58314,10114,04514,89114,84014,995
Total liabilities and equity46,83546,35245,30246,04044,16547,61248,43352,62754,53258,573

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-3502,5091937141981,5622,1173,3032,3462,768
Depreciation and amortization1,7631,7361,7251,7141,7211,8422,0092,0712,2192,347
Stock-based compensation73785557528173779993
Deferred income tax-26-2,012220379108509431981506744
Change in inventory-258-165-28-139-11013-9-45
Change in payables35118-93-46-7643410-1,009139115
Cash from operations4,1553,0893,2933,6933,4963,9454,8895,9384,9745,898
Capital expenditures-2,051-2,399-3,256-2,109-1,239-1,239-2,253-2,516-2,573-4,893
Acquisitions000-7280-151-933-1,568-2,244-1
Cash from investing-891100-2,725-2,827-1,558-1,465-3,375-3,891-4,863-5,489
Debt issued6,5283,3333,9267673,8992,1551,7552,7553,5944,940
Debt repaid-7,091-5,925-3,204-909-3,841-894-2,876-634-2,946-2,827
Stock issued92,131151099546109
Share buybacks0-9-13000
Dividends paid-1,261-992-1,386-1,842-1,941-1,992-2,071-2,179-2,316-2,442
Cash from financing-3,194-2,460-1,299-745-2,085-942-3,042-49-2,201-406
Net change in cash70729-731121-1471,538-1,5281,998-2,0903
Free cash flow2,104690371,5842,2572,7062,6363,4222,4011,005
Interest paid1,1521,1101,0641,1531,1491,1371,1171,152
Income taxes paid52811133168162

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $69.26 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Operating margin30.2%Operating income / revenue.
EBITDA margin45.3%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin27.5%Pre-tax income / revenue.
Net margin19.9%Net income / revenue.
FCF margin-0.7%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin38.8%Cash from operations / revenue.
Effective tax rate23.5%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)23.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)5.1%Net income / average total assets.
Return on invested capital (ROIC)8.2%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue0.5%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue39.5%Capital expenditures / revenue.
D&A / revenue15.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y17.9%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-5.7%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y14.1%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y25.7%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y11.6%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y13.8%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y17.7%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y9.2%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y10.8%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y17.7%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y8.5%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y65.5%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y17.6%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y8.6%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y66.0%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y18.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y6.5%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y11.0%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-58.1%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-27.5%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-14.9%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y5.3%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y5.6%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y4.6%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y3.0%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y3.7%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y1.7%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y7.4%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y6.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y5.8%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.2%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.48xCurrent assets / current liabilities.
Quick ratio0.33x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.03x(Cash + short-term investments) / current liabilities.
Debt / equity2.30xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets50.0%Total debt / total assets.
Liabilities / assets74.6%Total liabilities / total assets.
Net debt$30.12BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA4.31xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage3.13xOperating income / interest expense.
Working capital-$3.42BCurrent assets - current liabilities.
Tangible book value$13.19BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.25xRevenue / average total assets.
Fixed asset turnover0.35xRevenue / average property, plant and equipment.
Receivables turnover7.84xRevenue / average receivables.
Days sales outstanding47 days365 x average receivables / revenue.
FCF conversion-3.5%Free cash flow / net income, when net income is positive.
Capex / operating cash flow101.8%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$2.51Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$12.60Revenue / diluted weighted shares.
FCF per share-$0.09Free cash flow / diluted weighted shares.
Operating cash flow per share$4.89Cash from operations / diluted weighted shares.
Book value per share$10.77Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$10.77Tangible book value / shares outstanding.
Cash per share$0.17(Cash + short-term investments) / shares outstanding.
Payout ratio81.5%Dividends paid / net income, when net income is positive.

Valuation

MetricValueHow it is calculated
Market cap$84.72BShare price x shares outstanding.
Enterprise value$114.83BMarket cap + total debt - cash - short-term investments.
P/E27.6xMarket cap / net income. Only when net income is positive.
P/S5.49xMarket cap / revenue.
P/B6.42xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book6.42xMarket cap / tangible book value, when positive.
P/OCF14.1xMarket cap / cash from operations, when positive.
EV/Sales7.44xEnterprise value / revenue.
EV/EBIT24.6xEnterprise value / operating income, when both are positive.
EV/EBITDA16.4xEnterprise value / EBITDA, when both are positive.
FCF yield-0.1%Free cash flow / market cap.
Earnings yield3.6%Net income / market cap (the inverse of P/E).
Dividend yield3.0%Dividends paid over the period / market cap.
Shareholder yield3.0%(Dividends paid + share buybacks) / market cap.
PEG3.20xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was WILLIAMS COMPANIES, INC.'s revenue in fiscal 2025?

WILLIAMS COMPANIES, INC. reported revenue of $14.90B for fiscal 2025, 17.9% higher than the year before.

Was WILLIAMS COMPANIES, INC. profitable in fiscal 2025?

Yes. Net income was $2.62B, a net margin of 17.6%.

How much free cash flow did WILLIAMS COMPANIES, INC. generate in fiscal 2025?

Cash from operations of $5.90B minus capital expenditures of $4.89B left free cash flow of $1.01B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to WILLIAMS COMPANIES, INC.